Skip to main content
    D

    Dermata Therapeutics Inc (DRMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.57
    -0.03 (-4.75%)

    Market Cap: $3.06M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Dermata Therapeutics Inc (DRMA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Dermata Therapeutics (DRMA) has a latest price of $0.57 on Nov 17, 2026, 82.0% below its 52-week high of $3.16. Its price fell 81.4% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 85.3%.

    Price Chart

    From Aug 2021 to Oct 2026, its highest month-end close was $13,913.04 in Aug 2021 and its lowest $0.78 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart DRMA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DRMA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 61.2%, and over 6 months it fell 51.7%. The month-end price fell 99.1% over the 3 years through Oct 2026, a compound annual decline of 79.4%.

    PeriodChange
    1 month-33.7%
    3 months-61.2%
    6 months-51.7%
    12 months-81.4%
    12 months, with dividends-81.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-99.1%-79.4%
    5 years-100.0%-85.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price fell 76.5%, and its weakest was 2023, when it fell 90.7%.

    YearCloseChange
    2026 through Oct 2026$0.78-66.6%
    2025$2.32-82.8%
    2024$13.50-85.2%
    2023$91.45-90.7%
    2022$981.11-76.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 39.4% below its 50-day average of $0.94 and 53.1% below its 200-day average of $1.22.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.57
    52-week high$3.16-82.0%
    52-week low$0.57+0.7%
    50-day average$0.94-39.4%
    200-day average$1.22-53.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.5%.

    MeasureValue
    1-year beta1.22
    Largest fall, 1 year-81.8%
    Largest fall, 3 years-99.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About DRMA

    What is DRMA's 1-year price change?

    Dermata Therapeutics's price fell 81.4% over the past 12 months. With dividends included, the 12-month total return was -81.4%.

    What is DRMA's 5-year price change?

    Dermata Therapeutics's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 85.3%. These figures leave out dividends.

    What is DRMA's 52-week high and low?

    Dermata Therapeutics's 52-week high is $3.16 and its 52-week low is $0.57. Its latest price of $0.57 on Nov 17, 2026 is 82.0% below the high.

    What is DRMA's beta?

    Dermata Therapeutics's 1-year beta against the S&P 500 is 1.22, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 81.8%.

    Is the DRMA chart free?

    Yes. Advanced Charting for DRMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.